Back to Search
Start Over
Mechanistic insights into P-glycoprotein ligand transport and inhibition revealed by enhanced molecular dynamics simulations.
- Source :
-
Computational and structural biotechnology journal [Comput Struct Biotechnol J] 2024 Jun 13; Vol. 23, pp. 2548-2564. Date of Electronic Publication: 2024 Jun 13 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- P-glycoprotein (P-gp) plays a crucial role in cellular detoxification and drug efflux processes, transitioning between inward-facing (IF) open, occluded, and outward-facing (OF) states to facilitate substrate transport. Its role is critical in cancer therapy, where P-gp contributes to the multidrug resistance phenotype. In our study, classical and enhanced molecular dynamics (MD) simulations were conducted to dissect the structural and functional features of the P-gp conformational states. Our advanced MD simulations, including kinetically excited targeted MD (ketMD) and adiabatic biasing MD (ABMD), provided deeper insights into state transition and translocation mechanisms. Our findings suggest that the unkinking of TM4 and TM10 helices is a prerequisite for correctly achieving the outward conformation. Simulations of the IF-occluded conformations, characterized by kinked TM4 and TM10 helices, consistently demonstrated altered communication between the transmembrane domains (TMDs) and nucleotide binding domain 2 (NBD2), suggesting the implication of this interface in inhibiting P-gp's efflux function. A particular emphasis was placed on the unstructured linker segment connecting the NBD1 to TMD2 and its role in the transporter's dynamics. With the linker present, we specifically noticed a potential entrance of cholesterol (CHOL) through the TM4-TM6 portal, shedding light on crucial residues involved in accommodating CHOL. We therefore suggest that this entry mechanism could be employed for some P-gp substrates or inhibitors. Our results provide critical data for understanding P-gp functioning and developing new P-gp inhibitors for establishing more effective strategies against multidrug resistance.<br />Competing Interests: The authors declare no conflict of interest.<br /> (© 2024 The Authors.)
Details
- Language :
- English
- ISSN :
- 2001-0370
- Volume :
- 23
- Database :
- MEDLINE
- Journal :
- Computational and structural biotechnology journal
- Publication Type :
- Academic Journal
- Accession number :
- 38989058
- Full Text :
- https://doi.org/10.1016/j.csbj.2024.06.010